Preliminary study of the theophylline chronopharmacokinetics by salivary assay;Etude preliminaire de la chronopharmacocinetique de la theophylline a partir de prelevements salivaires

Journal de Pharmacie Clinique

Volumn 16, Issue 1, 1997, Pages 60-64

  Paysse, H ^a   Fagiolino, P ^a   Vazquez, M ^a   Beyssac, E ^b   Cardot, J M ^c   Alache, J M ^b  

^a Lab Pharmacologie et de Biopharm   (Uruguay)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c NONE

Author keywords

chronopharmacokinetics; saliva; theophylline

Indexed keywords

THEOPHYLLINE;

ADULT; ARTICLE; CHRONOPHARMACOLOGY; DRUG PROTEIN BINDING; DRUG SALIVA LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS;

EID: 0030982346     PISSN: 02911981     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Asegawa T, Takagi K, Ogura Y, Yamaki K, Suzuki R, Watanabe T, Satake T. Studies ont the temporal variations in the pharmacokinetics and metabolism of theophylline. Chem Pharm Bull 1979; 35: 2079-84.
2. Nomura K, Adachi K, Saitou H, Akimoto K, Katsunuma T, Hashimoto K, Iikura Y. Comparison of circadian variation of serum theophylline concentration between slo-bid and theolong in asthmatic children. Chem Abstract 1993; 119; 62371.
3. Saint-Pierre MV, Spino M, Isles AF, Tesoro A, Macleod SM. Temporal variation in the disposition of theophylline and its metabolites. Clin Pharmacol Ther 1985; 38: 89-95.
4. Jackson SHD, Johnston A, Woollard R, Abrams SML, Turner P. Circadian variation in theophylline absorption during chronic dosing with a slow release theophylline preparation and the effect of clock time of dosing Br J Clin Pharmacol 1988; 26: 73-7.
5. Regazzi MB, Rondanelli R, Vida E, Farinelli F, Upton RA. A theophylline dosage regimen which reduces round the clock variations in plasma concentrations resulting from diurnal pharmacokinetic variation. Eur J Clin Parmacol. 1987; 33: 243-7.
6. Samaans S, Fox R, Bukantz S, Lockey R. Comparison of nocturnal and diurnal theophylline levels at steady state. Ann Rev Chronopharmacol 1984; 1: 6972.
7. Schall R, Middle MV Mueller FO, De Plessis JB. Theophylline dose-concentration relationship of a 12-hourly Nuelin SA regimen supplemented with nocturnal Nuelin liquid in healthy volunteers. Chronobiol Int 1993; 10: 224-33.
8. Harrison LI, Kehe CR, Ekholm BP, Chang SF, Lavoie KA, Kisicki JC, Comparative pharmacokinetics of morning and evening doses of once-a-day theophylline capsules. J Pharm Sci 1994; 83: 1171-4.
9. Siegel IA, Ben-Aryeh H, Gozal D, Colin AA, Szargel R, Laufer D. Comparison of unbound and total serum theophylline concentrations with those of stimulated and unstimulated saliva in asthmatic children. Ther Drug Monit 1990; 12: 460-4.
10. Trnavska Z, Rejholec V, Elis J, Spicak V. Comparative pharmacokinetic analysis of theophylline in serum and saliva, Int J Clin Pharm Res 1987; 7: 329-35.
11. Fagiolino P. Monitorizacion de farmacos en saliva: ventaias e inconvenientes. Acta Farm Bonaerense 1990; 9: 3-13.
12. Fagiolino P, Vazquez M, Aiache JM, Modamio P, Marino EL. The use of saliva in bioavailability studies and pharmacokinetic monitoring, Int J Expl Clin Chemother (sous presse).
13. Posti J. Saliva-plasma drug concentrations ratios during absorption: theoretical considerations and pharmacokinetic implications. Pharm Acta Helv 1982; 57: 83-92.
14. Kamali F, Fry JR, Bell GD. Salivary secretion of paracetamol in man. J. Pharm Pharmacol 1987; 39: 150-2
15. Jusko WJ, Schentag JJ, Clark JH, Gardner M, Yurchak AM, Enhanced biotransformations of theophylline in marihuana and tobacco smokers. Clin Pharmacol Ther 1978; 24: 406-10.
16. Lesko LJ. Nonlinear kinetics and theophylline elimination. In: Pharmacokinetic basic for drug treatment, ed. L.Z. Benet, et al. New York: Raven Press, 1984; 321-32.
17. Lesko LJ, Tabor KJ, Johnson BF. Theophylline serum protein binding in obstructive airways disease. Clin Pharmacol Ther 1981; 29: 776-81.
18. Resar RK, Walson PD, Fritz WL, Perry DF, Barbée RA. Kinetic of theophylline. Variability and effect of arterial pH in chronic obstructive lung disease. Chest 1979; 76: 11-6.
19. Shan LM, Fields L, Mayock R. Factors influencing theophylline serum protein binding. Clin Pharmacol Ther 1982; 32; 490-6.
20. Patel IH, Venkataramanan R, Levy RH, Viswanathan CT, Ojemann LM. Diurnal oscillations in plasma protein binding of valproic acid. Epilepsia 1982; 23: 283-90.
21. Spectror AA, Fletcher JE. Nutritional effects on drug-protein binding. In: Nutrition and drug interrelations, ed J.N. Hathcock - J. Coon. New York, San Francisco, London: Academic Press 1978; 447-73.
22. Mitenko PA, Ogilvie RI. Rapidly achieved plasma concentration plateaus with observations on theophylline kinetics. Clin Pharmacol Ther 1972; 13: 329-35.